Home » Drug Delivery » Specialty Drug Delivery » Patient Controlled Analgesia to 2022

Patient Controlled Analgesia to 2022


Chart_Collage_160   Published June 2015  •  Catalog no. PCA477R  •  Price US $3,850



An increasing understanding of the physiology of pain coupled with patient-friendly dosage forms and delivery techniques is providing caregivers and prescribers with improved tools for helping patient manage their own pain. New and emerging pain delivery products that allow patients to play an active role in the timing and dosing of their pain medication allow patients to balance pain relief and medication side effects, and potentially improve quality-of-life. Pain management philosophy is based on the premise of treating pain early and aggressively. This is based on research that pain is tightly correlated with decreased quality of life, and increased incidence of anxiety and depression. Further, pain causes the physiologic release of destructive enzymes that can damage even healthy tissue. The aging population – particularly in North America and Western Europe, where the quality of medical care is high and consumers enjoy a relatively high standard of living – will create a growing market of mature and elderly needing drug therapies and pain management for a variety of maladies associated with the aging process. These factors are attracting well-financed players and elevating alliance activity in this sector.

Bar_Graph   Patient Controlled Analgesia Report Prospectus (Download PDF)

Blue document   Patient Controlled Analgesia Report Order Form (Download PDF)


Highlights

• Analyzes and evaluates patient controlled analgesia (PCA) products and assesses the market potential for existing and probable future products
• Analyzes product designs, technologies and market development issues
• Provides detailed descriptions of PCA market segments, market demographics, and business strategies
• Provides market data and forecasts to 2022
• Profiles PCA product companies, their product development activities, business strategies, and corporate alliances and affiliations
• Assesses the importance of pharma-device alliances and design partnerships
• Evaluates the impact of economic, technology, and regulatory factors on PCA markets

 


Summary of Contents

 

Executive Summary

Pain Management Market Dynamics

Tracking the Growth of PCA

Demand Drivers

Demographic Shifts

Evolving Pain Management Guidelines

Growth in Self-Administration

Technology Market Drivers

PCA Market Strategies

PCA Design Factors

Patient Usability

Medication Errors and Safety

Dose and Lockout Intervals

Bolus Dosing

PCA Device Assessments

Infusion Pumps

In-Patient/Bedside PCA Infusion

Ambulatory PCA Infusion

Active Transdermal Systems

Development-Stage PCA Devices

Intranasal Sprays

Sublingual Sprays

Pulmonary (Systemic)  Inhalers

PCA Market Assessments and Analysis

PCA Market Segments

In-Patient

Ambulatory

Home Care

PCA Indications

Trauma

Post-Operative/Obstetric Pain

Cancer Pain

Chronic Pain

Nociceptive Pain

Neuropathic Pain

Market Factors

Healthcare Regulations

Industry Standards

Managed Care Initiatives

Caregiver Training & Patient Monitoring

Market Data & Forecasts

North America

Europe

Japan

Other Geographies

Sector Participant Company Profiles